Enforcement Vancouver dispensaries ruling supports civic power to license illegal businesses: lawyer 'The number one takeaway from this case is that it is very supportive of a municipality’s ability to govern cannabis businesses' Nick LabaFebruary 10, 2020
CBD GemmaCert tech tests if weed is cannabis or legal US hemp in minutes GemmaCert could prevent mistaken drug busts and benefit medical cannabis patients Michelle GamageFebruary 7, 2020
Culture WhatsMyPot matches you with your best bud The free web service recommends your ideal strains based on a database of product descriptions and over 600 medical articles Nick LabaFebruary 5, 2020
Canada Aurora Rivers facility certified to ship medical cannabis to EU Three out of 10 Canadian facilities are now EU GMP certified Michelle GamageFebruary 4, 2020
Medical and Pharmaceutical GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex Michelle GamageFebruary 3, 2020
Canada Canadian doctor says Tide Pods pose greater health threat than cannabis edibles Dr. Ian Mitchell of Kamloops is calling out medical professionals across Canada for spreading misinformation on pot Jared GnamJanuary 30, 2020
Driving RoadSafetyBC flags chronic patient for cannabis use only after legalization Stephanie deJager says her weed use and other meds had been documented for years, but last November cannabis appeared in a letter for the... Nick LabaJanuary 28, 2020
Investment Ideas WeedMD CEO says medical cannabis shouldn’t be taxed, 2020 will be a shakeout: Q&A Learn what the executive has to say about enforcing the illicit market, and if he's ever smoked weed himself Nick LabaJanuary 24, 2020
Canada Aphria gains EU GMP certification to ship medical cannabis within Europe The Ontario producer will be able to ship anywhere inside the 28-member European Union Jared GnamJanuary 21, 2020
Medical and Pharmaceutical Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December Nick LabaJanuary 20, 2020